🇺🇸 FDA
Patent

US 10500194

Covalent small molecule DCN1 inhibitors and therapeutic methods using the same

granted A61KA61K31/428A61K31/454

Quick answer

US patent 10500194 (Covalent small molecule DCN1 inhibitors and therapeutic methods using the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/428, A61K31/454, A61K31/497, A61K31/5377